Press Enter for full results

Best Supplements to Take With CJC-1295 (No DAC)

13 min read Cjc 1295 No Dac

AI Summary

CJC-1295 (No DAC) tells the pituitary to fire a short, sharp growth hormone pulse and then steps back. That pulse drives IGF-1 production in the liver, which in turn signals muscle protein synthesis, fat mobilization, and tissue repair. But the pulse landing is only half the equation. For the signal to fully execute, the pituitary needs zinc to maintain the receptor it binds to, vitamin D to complete the calcium-dependent release step, and adequate amino acids downstream so the resulting IGF-1 signal has raw material to work with. The synergists in this stack, glycine, melatonin, L-citrulline, and GABA, amplify the same nocturnal GH pulse the peptide aligns with, while creatine ensures that elevated IGF-1 has sufficient training demand to convert into retained lean mass. There are no dose numbers on this page because the right amount of each supplement depends on your protocol, your bloodwork, and what else you are already taking. MyPeptidePal works that out for you.

CJC-1295 (No DAC) Sends the Signal. This Is What Makes the Signal Land.

Don't guess when it comes to peptides. Use My Peptide Pal.

CJC-1295 (No DAC) is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone, the body's own signal that tells the pituitary gland to release growth hormone. It binds the same receptor that endogenous GHRH binds to, triggers the same downstream cascade, and then clears in roughly 30 minutes. What you get is a sharp, discrete pulse of growth hormone that looks a great deal like what a healthy pituitary produces naturally: elevated and concentrated over a short window rather than spread across days.

This is the defining pharmacokinetic fact about CJC-1295 (No DAC), and it is what separates it most meaningfully from its nearest sibling. CJC-1295 with DAC uses a technology that allows the peptide to bind to albumin in the bloodstream and remain active for six to eight days, producing a tonic, sustained GH elevation that never fully turns off between doses. The No DAC version does nothing of the kind. Once the 30-minute window closes, the receptor recovers, the feedback loop resets, and the body waits for the next signal. That pulsatile pattern is biologically closer to what the body does on its own, and it is precisely why the No DAC form is favored when the goal is to amplify natural GH rhythm rather than override it. The No DAC variant also carries meaningfully less risk of the water retention, numbness, and sustained insulin resistance that can accumulate with the tonic GH elevation the DAC version produces.

The pulsatile nature of CJC-1295 (No DAC) has a direct consequence for supplement strategy. Because GH spikes briefly and then fades, the downstream effects, including the IGF-1 rise in the liver and the subsequent protein synthesis signal in muscle, depend on the body being ready to execute when the pulse arrives. A pituitary running low on the minerals required to complete the GH release cascade will partially execute the signal. Muscle tissue without adequate amino acid availability will receive an anabolic signal it cannot fully act on. A sleep environment not optimized for deep, slow-wave sleep will miss the amplification that comes from aligning the peptide's pre-bed dosing with the body's own nocturnal GH pulse.

That is the argument for this supplement stack. Not that the supplements help in a generic sense, but that each one addresses a specific point in the chain between the receptor activating and the result appearing. CJC-1295 (No DAC) is dosed daily, typically pre-bed or pre-workout, and the fasted-state timing is practically important: carbohydrates and fat near the injection raise insulin, and elevated insulin triggers somatostatin release, which is the pituitary's off-switch for GH secretion. The supplements here are structured around that cadence. The minerals that support pituitary signaling are taken in the evening window. The protein and training support are spread across the day to be present when the anabolic signal arrives.

Where this guide comes from

Most peptide guides are written from whatever the author could find on the internet. This one is built on something different. The MyPeptidePal Knowledge Base aggregates every published clinical study, peer-reviewed trial, in vitro finding, and documented human use case on peptides into a single continuously updated system. What makes it unique is the layer on top of the published literature: MyPeptidePal currently tracks over 10,000 active user protocols every day, with more than 900 new protocols created and refined daily by real users logging their actual results.

That means the dosing ranges, outcome timelines, and safety notes in this guide are not only sourced from published literature — they are cross-referenced against real-world protocol data from thousands of people actively using these compounds. When the research and the real-world data agree, we say so. When they diverge, we note it. The goal is the clearest, most complete picture of what the evidence actually shows.

The Supplements That Matter Most on CJC-1295 (No DAC)

Supplement Role Why it earns its slot
Protein and essential amino acids Cofactor and result preservation IGF-1 drives muscle protein synthesis, but only if amino acid raw materials are present; protein also preserves the lean mass accumulating over the protocol
Zinc Cofactor The pituitary requires adequate zinc to express the GHRH receptor that this peptide binds
Vitamin D Cofactor Vitamin D receptors in pituitary tissue regulate the calcium-dependent final step of GH release
Glycine Synergist Deepens slow-wave sleep, amplifying the nocturnal GH pulse this peptide is timed to align with
L-Arginine or L-Citrulline Synergist Inhibits somatostatin, the pituitary's GH off-switch, independently of the GHRH receptor pathway
GABA Synergist Has raised GH acutely in small human trials, providing a complementary GH-augmenting signal
Melatonin Synergist Reinforces deep sleep and has been shown to raise GH pre-bed, both effects converging with the peptide's timing
Creatine monohydrate Result preservation Enables higher training volume so that elevated IGF-1 has sufficient physical demand to drive adaptation

There are no dose numbers on this page. The right amount of each of these depends on your actual peptide protocol, your bloodwork, and everything else you are currently taking. MyPeptidePal personalizes the amounts for you based on those specifics.

What the Pituitary Needs to Execute the Signal

CJC-1295 (No DAC) binds a receptor and triggers a signaling cascade. That cascade is not self-sufficient. It depends on mineral concentrations inside pituitary cells, on calcium availability for the physical act of GH vesicle release, and on amino acids being present downstream when the anabolic signal lands. The supplements in this section are the raw materials the mechanism consumes.

Protein and Essential Amino Acids

This is the most important supplement on the list, and it works across two levers simultaneously, which is why it earns particular attention. On the cofactor side, IGF-1, the growth factor the liver produces in response to each GH pulse, drives muscle protein synthesis through a pathway called mTOR, but that pathway requires available amino acids as building blocks. Think of it this way: the peptide sends the construction crew their work orders, but the bricks still have to show up on site. Without amino acids in circulation, the IGF-1 signal fires into an empty substrate pool and the adaptation cannot happen.

On the result-preservation side, adequate protein intake is the primary defense against losing the lean mass the protocol is intended to build. Daily dosing of a GH secretagogue creates an ongoing anabolic environment, but that environment erodes quickly when protein is insufficient. This double-duty role means protein is the one item on this stack where skimping produces a compounding cost: it simultaneously limits the signal's execution and allows losses to accumulate.

The leucine content of protein matters specifically here. Leucine is the amino acid that activates mTOR, the molecular switch that converts the IGF-1 signal into actual protein synthesis. A meal that reaches an adequate total protein number but with insufficient leucine per serving may not reliably trigger that switch, which means the GH pulse partially passes through without producing the adaptation it was meant to drive.

Zinc

Zinc is required for the pituitary gland to express the GHRH receptor at adequate density. This is the most upstream bottleneck in the entire stack. CJC-1295 (No DAC) is a binding molecule. If the docking site it binds to is under-expressed because zinc levels are insufficient, the peptide has fewer places to land, and the GH response is blunted before the signaling cascade even starts. Zinc deficiency does not just reduce downstream output; it reduces the receptor population that the entire protocol depends on.

Zinc deficiency is more common than most supplement discussions acknowledge. Dietary zinc is concentrated in red meat, shellfish, and seeds, and is absorbed less efficiently from plant sources because phytate, a compound found in grains and legumes, competes with zinc for absorption. Athletes and people eating high-carbohydrate, lower-animal-protein diets face a meaningful risk. The evidence that zinc supports GH axis function is drawn from clinical research on the GH axis broadly, rather than from trials specifically testing zinc alongside this peptide, but the receptor-expression mechanism is well established in the endocrinology literature.

One caution relevant to zinc is addressed directly in the cautions section below: chronic high-dose zinc supplementation competes with copper absorption, which creates a separate deficiency risk over extended protocols.

Vitamin D

Vitamin D receptors are present in pituitary tissue, and they influence calcium signaling inside the somatotroph cells where GH is stored and released. The physical act of releasing a GH pulse is calcium-dependent: calcium floods the cell, triggering the GH-containing vesicles to fuse with the cell wall and release their contents. Vitamin D deficiency disrupts this calcium signaling process, reducing the efficiency of each individual pulse discharge.

This efficiency loss matters more for CJC-1295 (No DAC) than it would for a tonic compound. Because the No DAC version produces short, discrete pulses, each one either fires cleanly or it does not. There is no sustained baseline to compensate over time. A calcium signaling defect that shaves off a portion of each pulse's output accumulates across every daily dose.

Vitamin D deficiency is strikingly common, particularly in people living at higher latitudes, working predominantly indoors, or with higher skin melanin concentrations, all of which limit UV-driven synthesis. Correcting a frank deficiency is a straightforward intervention with a plausible and well-grounded mechanism for improving results. Vitamin D is fat-soluble, so it should be taken with the largest meal of the day rather than near the fasted injection window.

Where the Signal Gets Amplified

GH secretion from the pituitary is influenced by multiple pathways simultaneously. The GHRH receptor is the primary stimulatory one, but it is not the only door. These supplements push the same direction through separate mechanisms, and because the mechanisms are genuinely distinct, their effects combine rather than overlap.

Glycine

Glycine is a conditionally essential amino acid with a well-supported role in sleep quality. It works partly by reducing core body temperature, facilitating the transition into deep, slow-wave sleep, which is the sleep stage during which the body generates its largest natural GH pulse of the night. CJC-1295 (No DAC) is most commonly dosed pre-bed specifically to align with and amplify this nocturnal pulse. Glycine taken in the same window supports the sleep architecture that makes that alignment meaningful.

The evidence for glycine's sleep effects comes from controlled human trials, placing it on more solid ground than most sleep-support supplements. Users report falling asleep more readily and experiencing better sleep quality, and the body-temperature mechanism supports those reports. What has not been formally tested is whether glycine meaningfully raises GH pulse magnitude in peptide users specifically, so treat the sleep-architecture benefit as the primary mechanism and the GH amplification as a plausible secondary one.

L-Arginine or L-Citrulline

L-Arginine stimulates GH release from the pituitary through a mechanism that operates independently of the GHRH receptor. It appears to inhibit somatostatin, the hormone that tells the pituitary to stop releasing GH. Less somatostatin activity means the GH pulse triggered by the peptide can rise higher and the release window stays open a little longer.

The GH-stimulating effect of arginine has been tested in human subjects, though the magnitude is modest in people with normal baseline GH function. The combination with exercise is where the evidence is more consistent: arginine taken before training appears to extend the duration of the exercise-induced GH spike rather than dramatically raising its peak. For a pre-workout dosing schedule, that extension is a genuine additive effect.

L-Citrulline deserves mention alongside arginine because citrulline is converted to arginine in the kidneys and typically delivers a more sustained and better-absorbed arginine supply than arginine powder taken directly. If the goal is raising arginine availability, citrulline tends to accomplish it more reliably. Choose one or the other; there is no meaningful additive benefit from taking both simultaneously.

The arginine-somatostatin interaction is well established in endocrinology. Trials specifically combining arginine with CJC-1295 (No DAC) do not exist. The inclusion here is an extension of what is known about arginine's GH-modulating properties, not a directly tested combination, and it should be understood that way.

GABA

GABA is the brain's primary inhibitory neurotransmitter, meaning its job is to reduce activity in the neural circuits it acts on. Taken orally, it has raised GH acutely in small human studies, likely through inhibition of hypothalamic pathways that regulate somatostatin tone. The practical question the research has not fully resolved is how much of the oral dose crosses the blood-brain barrier, the tightly regulated boundary between the bloodstream and the brain, since the hypothalamic targets GABA would need to reach are on the brain side of that barrier. Some evidence points to peripheral GABA signaling playing a role independent of central penetration, but the mechanism is not fully established.

GABA belongs on this stack with honest expectations. The GH-raising effect in published trials is real and reproducible in the studies that have tested it, but modest. Community use of GABA alongside GH secretagogues is widespread, which is meaningful context about what people actually experience, but it is not a substitute for larger controlled trials. Think of GABA as a supporting synergist with a plausible mechanism and moderate community backing, not a primary intervention.

Melatonin

Melatonin drives the transition into deep sleep, reinforces circadian rhythm, and has been shown in controlled studies to raise GH secretion acutely when taken before bed. The mechanism likely involves melatonin's effects on hypothalamic somatostatin suppression, creating a slightly more permissive environment for GH release at the same time the peptide is being dosed.

The pre-bed combination of CJC-1295 (No DAC) with melatonin is among the more mechanistically coherent pairings in this stack. Both are taken in the same timing window, both support or amplify the nocturnal GH pulse, and both benefit from the same relative timing near sleep onset. Melatonin's GH-related effects have been observed in human studies, which places this pairing on stronger evidentiary ground than most of the synergist category.

The sleep-consolidating benefit is also worth noting separately. Better slow-wave sleep means the pituitary is in the optimal hormonal environment for GH secretion precisely when the peptide's signal arrives. The two effects reinforce each other rather than running in parallel.

Converting the Signal Into Results You Keep

Everything you need for peptides, health, and fitness in one app.

Elevated GH and IGF-1 create an anabolic environment. They do not automatically fill that environment with muscle. The IGF-1 signal tells the body to build tissue, but it responds in proportion to the physical demand placed on that tissue. Without training stimulus and without the energetic capacity to train effectively, the signal increases potential without increasing output.

Creatine Monohydrate

Creatine is the most extensively studied performance supplement in sports science, and its role here is direct. Muscles use a molecule called ATP as their immediate energy currency during effort. During high-intensity work, ATP is depleted faster than the body can regenerate it, and performance falls off. Creatine is stored in muscle cells as phosphocreatine, a reservoir that rapidly regenerates ATP during those high-demand moments, allowing the muscle to sustain harder effort slightly longer before fatigue sets in.

This matters for CJC-1295 (No DAC) because IGF-1 drives muscle protein synthesis in proportion to the mechanical stress the muscle is under. Higher training volume and intensity, made possible by creatine, means more stress and therefore a larger adaptive signal for the elevated IGF-1 to respond to. The two pathways are genuinely separate: creatine supplies the energy substrate, and the peptide raises the hormonal driver that converts that energy expenditure into tissue. They address different bottlenecks in the same adaptive process and do not interfere with each other.

One thing worth knowing for bloodwork interpretation: creatine supplementation raises serum creatinine, a marker routinely used to assess kidney filtration. This is a completely normal consequence of creatine metabolism, not a sign of kidney stress in healthy people. A blood panel taken during creatine use will often show a creatinine value that looks mildly elevated on reference ranges, which can alarm people who are not expecting it. It is a metabolic artifact of the supplement, not a reason to stop.

What to Avoid and What to Watch

Active Malignancy or Recent Cancer History

This warning leads this section because it is the most consequential. GH and IGF-1 are mitogenic, meaning they stimulate cell division and growth. In healthy tissue, this is the mechanism behind the anabolic and repair effects that make this peptide useful. In cancer cells, the same stimulation can accelerate tumor growth and proliferation. CJC-1295 (No DAC) is absolutely contraindicated in anyone with an active malignancy or a cancer history within the past five years. This is not a precautionary hedge; it is a hard limit with a clear mechanistic basis.

Fasted Dosing Is Not Optional

The most common performance mistake with CJC-1295 (No DAC) is injecting too close to a carbohydrate or fat-containing meal. When blood glucose rises after eating, the body releases insulin, and elevated insulin promotes somatostatin release. Somatostatin is the pituitary's GH off-switch. Dosing into an insulin-elevated environment blunts or eliminates the GH pulse the peptide is supposed to produce. The injection should be timed at least two to three hours after the last full meal, or first thing in the morning in a fasted state. A very small, low-fat snack of roughly 100 to 150 calories with minimal carbohydrate may be used to manage nausea without significantly raising insulin, but a full carbohydrate-rich meal in the window around injection defeats the purpose.

Somatostatin Analogs

Medications in the somatostatin analog class, including octreotide and lanreotide, are used clinically for acromegaly and certain neuroendocrine tumors. They directly suppress GH release from the pituitary. Taking a somatostatin analog alongside CJC-1295 (No DAC) does not partially reduce the peptide's effect; it negates it entirely. This combination should be avoided.

Insulin and Blood Sugar Medications

GH is counter-regulatory to insulin. When GH rises, it reduces the ability of muscle and fat cells to take up glucose from the bloodstream. In someone managing diabetes or using insulin therapeutically, this effect can meaningfully disrupt glucose control and may require insulin dose adjustments. This interaction requires close collaboration with a prescribing clinician. It is not something to navigate with a supplement change.

Zinc Excess and Copper Depletion

Zinc and copper compete for absorption in the gut. Using zinc at higher doses over extended periods without corresponding copper intake progressively depletes copper levels. Copper deficiency is associated with a form of anemia that does not respond to iron treatment, along with neurological symptoms and immune dysfunction. Anyone supplementing zinc at therapeutic rather than maintenance doses for extended periods should add a small copper supplement alongside it, and periodic monitoring of copper status on a long protocol is reasonable.

Levothyroxine and Thyroid Panels

GH accelerates the conversion of T4, the inactive form of thyroid hormone, into T3, the active form. In someone on a stable levothyroxine dose, this acceleration can lower their circulating T4 levels more rapidly than expected and may require a dose adjustment. The interaction is not acutely dangerous but can shift thyroid hormone balance enough to affect symptoms and warrants a thyroid panel recheck within the first weeks to months of starting this protocol.

Frequently Asked Questions

How much of each supplement should I take with CJC-1295 (No DAC)?

There are no dose numbers on this page, and that is deliberate. The right amount of protein, zinc, vitamin D, and the other supplements here depends on your specific CJC-1295 protocol, your current bloodwork, your body composition, and what else you are already taking. A zinc dose that corrects a deficiency in one person is unnecessary for another with adequate zinc status. MyPeptidePal takes your protocol and your labs and works out the specific amounts for you.

Which blood markers actually matter when running CJC-1295 (No DAC)?

IGF-1 is the primary efficacy marker: it should rise with sustained use and confirms the pituitary is responding to the peptide. Fasting glucose and fasting insulin are worth tracking because GH reduces insulin sensitivity, and this can increase over a long protocol, particularly at higher doses. Thyroid function, specifically T4 and free T3, is relevant if you are on levothyroxine or have any thyroid history, since GH accelerates T4-to-T3 conversion. Serum zinc and 25-OH vitamin D will tell you whether the two primary pituitary-level cofactors are actually present in sufficient amounts.

Do these supplements interfere with how CJC-1295 (No DAC) works?

None of the supplements on this list have a negative pharmacodynamic interaction with the peptide itself. The one timing consideration that matters is protein intake: a large, carbohydrate-heavy meal near the injection window raises insulin, which can partially blunt the GH pulse. Space a substantial meal appropriately away from the injection, or keep any pre-injection snack small and low in carbohydrates. Beyond timing, the supplements here are designed to support the mechanism, not compete with it.

Can I just eat well and skip the supplements?

For several of these, yes. If your bloodwork shows adequate zinc, vitamin D, and your protein intake is consistently strong from whole food sources, the supplemental forms may add little. The supplements become most relevant when there is an actual deficiency or a meaningful gap, not as insurance for someone already nutritionally optimized. The honest picture is that zinc and vitamin D shortfalls are genuinely common in athletes and people who work predominantly indoors, which is why they appear here rather than being covered by a general eat-well recommendation. Get your bloodwork first, then decide what is actually missing.

Do I need to keep taking these after I stop CJC-1295 (No DAC)?

The supplements addressing underlying deficiencies, zinc, vitamin D, magnesium, remain relevant regardless of whether you are running the peptide because those deficiencies carry their own costs independent of GH axis function. Protein and creatine are tools for building and maintaining lean mass whose value does not disappear when the protocol ends. The synergists oriented toward GH pulse amplification, glycine, melatonin, GABA, and L-citrulline, are specifically tuned to the pre-bed dosing window and the nocturnal GH pulse, and their relevance naturally decreases once you are no longer dosing a GH secretagogue daily.

Ready to turn this stack into numbers?

This guide explains which supplements earn their slot. What it can't tell you is how much of each — that depends on your protocol, your bloodwork, and everything else you're running. That's what MyPeptidePal does. Build my plan in under 60 seconds, free.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of CJC-1295 (No DAC) and the nutrients that support it in one place.

Getting your peptide information from reddit

About MyPeptidePal

MyPeptidePal is the world's largest peptide knowledge base and your personal AI peptide expert in one. Trained on every published study and over 10,000 protocols, it gets smarter every day, learning from new research and a community actively running and tracking their own. Build a personalized protocol in 60 seconds, get dosing math you can trust, find vetted suppliers, set auto-pilot reminders, and get straight answers on peptides, health, fitness, and longevity, all in one place. Try for FREE Here, no credit card required.

About the Author

Marcus Reid

Marcus Reid is a functional medicine researcher, data analyst, and peptide specialist, and one of the people who built MyPeptidePal. The platform exists in part because of the years he spent immersed in clinical literature, real-world protocols, and the kind of hands-on experimentation that most textbooks skip entirely. He is not a physician and does not pretend to be. What he is, is someone who has done the work to understand how these compounds actually function at a biological level, what the research actually says versus what the forums claim, and how to explain it in a way that makes sense to anyone willing to learn. At MPP, Marcus contributed to building the knowledge base, the protocol frameworks, and the research systems that power the platform. His work covers tissue repair, metabolic health, hormonal optimization, longevity, cognitive function, and cosmetic applications. When the science gets complicated, his job is to make it click.